NSAIDs and gastrointestinal complications: New clinical challenges

Neena Susan Abraham, David Y. Graham

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The use of NSAIDs is associated with significant risk of upper gastrointestinal ulcer, bleeding, perforation and stricture. NSAIDs vary in their analgesic and anti-inflammatory properties; choice of NSAID, dosage and duration are the cornerstone of rationale therapy. Proton pump inhibitors are widely used to reduce the risk of serious events, despite the paucity of data that indicates that they are effective for this indication. The existing recommendations for prevention of gastrointestinal toxicity are reviewed in this article, in light of new clinical challenges posed by the emerging data regarding competing cardiovascular risk. Strategies are proposed for common clinical prescribing dilemmas, new clinical risk groups are identified and preventative strategies for these special populations are recommended.

Original languageEnglish (US)
Pages (from-to)2681-2689
Number of pages9
JournalExpert Opinion on Pharmacotherapy
Volume6
Issue number15
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Non-Steroidal Anti-Inflammatory Agents
Proton Pump Inhibitors
Ulcer
Pathologic Constriction
Hemorrhage
Population
Therapeutics

Keywords

  • COX-2 inhibitor
  • Coxib
  • NSAIDs
  • Peptic ulcer
  • Upper gastrointestinal tract bleeding

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

NSAIDs and gastrointestinal complications : New clinical challenges. / Abraham, Neena Susan; Graham, David Y.

In: Expert Opinion on Pharmacotherapy, Vol. 6, No. 15, 12.2005, p. 2681-2689.

Research output: Contribution to journalArticle

@article{c2df46ba14de44f789659ae9d6431d34,
title = "NSAIDs and gastrointestinal complications: New clinical challenges",
abstract = "The use of NSAIDs is associated with significant risk of upper gastrointestinal ulcer, bleeding, perforation and stricture. NSAIDs vary in their analgesic and anti-inflammatory properties; choice of NSAID, dosage and duration are the cornerstone of rationale therapy. Proton pump inhibitors are widely used to reduce the risk of serious events, despite the paucity of data that indicates that they are effective for this indication. The existing recommendations for prevention of gastrointestinal toxicity are reviewed in this article, in light of new clinical challenges posed by the emerging data regarding competing cardiovascular risk. Strategies are proposed for common clinical prescribing dilemmas, new clinical risk groups are identified and preventative strategies for these special populations are recommended.",
keywords = "COX-2 inhibitor, Coxib, NSAIDs, Peptic ulcer, Upper gastrointestinal tract bleeding",
author = "Abraham, {Neena Susan} and Graham, {David Y.}",
year = "2005",
month = "12",
doi = "10.1517/14656566.6.15.2681",
language = "English (US)",
volume = "6",
pages = "2681--2689",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "15",

}

TY - JOUR

T1 - NSAIDs and gastrointestinal complications

T2 - New clinical challenges

AU - Abraham, Neena Susan

AU - Graham, David Y.

PY - 2005/12

Y1 - 2005/12

N2 - The use of NSAIDs is associated with significant risk of upper gastrointestinal ulcer, bleeding, perforation and stricture. NSAIDs vary in their analgesic and anti-inflammatory properties; choice of NSAID, dosage and duration are the cornerstone of rationale therapy. Proton pump inhibitors are widely used to reduce the risk of serious events, despite the paucity of data that indicates that they are effective for this indication. The existing recommendations for prevention of gastrointestinal toxicity are reviewed in this article, in light of new clinical challenges posed by the emerging data regarding competing cardiovascular risk. Strategies are proposed for common clinical prescribing dilemmas, new clinical risk groups are identified and preventative strategies for these special populations are recommended.

AB - The use of NSAIDs is associated with significant risk of upper gastrointestinal ulcer, bleeding, perforation and stricture. NSAIDs vary in their analgesic and anti-inflammatory properties; choice of NSAID, dosage and duration are the cornerstone of rationale therapy. Proton pump inhibitors are widely used to reduce the risk of serious events, despite the paucity of data that indicates that they are effective for this indication. The existing recommendations for prevention of gastrointestinal toxicity are reviewed in this article, in light of new clinical challenges posed by the emerging data regarding competing cardiovascular risk. Strategies are proposed for common clinical prescribing dilemmas, new clinical risk groups are identified and preventative strategies for these special populations are recommended.

KW - COX-2 inhibitor

KW - Coxib

KW - NSAIDs

KW - Peptic ulcer

KW - Upper gastrointestinal tract bleeding

UR - http://www.scopus.com/inward/record.url?scp=29244474359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244474359&partnerID=8YFLogxK

U2 - 10.1517/14656566.6.15.2681

DO - 10.1517/14656566.6.15.2681

M3 - Article

C2 - 16316306

AN - SCOPUS:29244474359

VL - 6

SP - 2681

EP - 2689

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 15

ER -